Skip to main content

Vancomycin-resistant enterococci in Spanish hospitals: the experience of official network for the surveillance of resistant microorganisms RedLabRA, 2023-2024

Journal
Frontiers in public health (Q1)
Published
29 October 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Javier E Cañada-García, Sara Pérez de Madrid, Estela Giménez Quiles, María Pilar Ortega-Lafont, María Dolores Tirado-Balaguer, Luis López-Urrutia, et al.
PMID
43021967
DOI
10.3389/fpubh.2026.1966902

Why clinicians should know about it

  • Picked for Microbiology (medical) (top studies of the week, 15 November 2026): National VRE genomic surveillance identifies interregional hospital clusters

Abstract

OBJECTIVES: RedLabRA is a network of microbiology laboratories for the genomic surveillance of antibiotic resistance. The aim of this study was to describe the actions undertaken by RedLabRA in response to an increase of vancomycin-resistant enterococci (VRE) in some Spanish regions. METHODS: RedLabRA designed a VRE surveillance organized in two phases: (1) a questionnaire to assess risk perception of VRE among the network's Level 2 laboratories (LN2), and (2) collection of cases detected between April 2023 and March 2024, followed by WGS of a sample of vancomycin-resistant Enterococcus faecium (VREfm) isolates to investigate interregional dissemination. WGS was performed using the Illumina platform; MLST (PubMLST.org scheme), cgMLST and phylogenetic relationships (Ridom SeqSphere+ v3.5.0), and resistome (Resfinder 4.7.2) were analysed. RESULTS: Nine of the 17 autonomous communities defined a priority scenario of VRE. 31 LN2 reported 1,958 VRE cases from 86 hospitals across 12 autonomous communities and the autonomous city Ceuta. The predominant species was E. faecium (97.1%). 317 VREfm isolates were included for WGS: 211 (66.6%) carried the vanA gene, 90 (28.4%) vanB, and 16 (5%) both genes. ST117 (34.7%), ST80 (27.1%), or ST1421 (25.6%) predominated. Using cgMLST (1,423 genes, cutoff of 5 alleles), 45 VREfm clusters were identified, of which eight involved at least three hospitals and were inter-regional. 51 (16.1%) isolates carried linezolid resistance mechanisms, mainly optrA+cfrD. CONCLUSION: VREfm had a highly uneven impact across Spanish regions. The inter-regional presence of VREfm isolates with high genetic similarity belonging to ST1421, ST117, and ST80 clones was detected. The emergence of E. faecium isolates carrying genes conferring resistance to vancomycin and linezolid requires ongoing surveillance.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.